Literature DB >> 8453029

Characterization of brain angiotensin II AT2 receptor subtype using [125I] CGP 42112A.

F M Heemskerk1, S Zorad, A Seltzer, J M Saavedra.   

Abstract

Recently two subtypes of angiotensin receptors have been described, AT1 and AT2. Currently used radiolabeled agonists and antagonists are not able to discriminate between these receptors subtypes. Here we characterize the use of [125I] CGP 42112A, a novel, specific ligand for AT2 receptors, in a membrane binding assay and in autoradiography of brain sections of 2 week old rats. [125I] CGP 42112A bound with high affinity and autoradiography revealed binding selectively localized to areas known to express the AT2 receptor subtype only. CGP 42112A, angiotensin II, angiotensin III and PD 123177 competed for [125I] CGP 42112A binding, with potencies consistent with high affinity and specific binding to AT2 receptors. Thus [125I] CGP 42112A will be a useful new tool to study AT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453029     DOI: 10.1097/00001756-199301000-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

Review 1.  The discovery of a novel macrophage binding site.

Authors:  Juan M Saavedra; Jaroslav Pavel
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

Review 2.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

3.  [125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.

Authors:  M Viswanathan; A M de Oliveira; R M Wu; C C Chiueh; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

4.  Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney.

Authors:  G M Ciuffo; F M Heemskerk; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.